BCAX

Bicara Therapeutics Inc. Common Stock

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$21.47

Market Cap

$1.18B

Beta

-0.77

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)-100.00%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-9.11%

Debt / Equity0.00

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for BCAX.